Thus, we have identified a novel compound, CCI-007, that selectively inhibits the viability of a subset of MLL-r, CALM-AF10 and SET-NUP214 leukemia cells, without affecting normal cells, solid tumour lines and other MLL-wt leukemia cells. Here, NUP214 is linked to leukemia.